Invitae Grows Its Genetic Testing Menu
In recent months, genetic testing company Invitae has dramatically expanded its test menu, focusing on diagnosing disease using a broad platform.
Fresenius CEO on Ways to Improve Chronic Care
The leader of dialysis giant Fresenius Medical Care North America shares how his company and others can work to help chronic care patients return to a more normal way of life.
FDA Makes Case for LDT Oversight
As part of its bid to bring laboratory developed tests under its jurisdiction, FDA details 20 examples illustrating how absence of agency oversight is or may be hurting patients who use LDTs.
How Do Micra Results Compare to Nanostim Data?
Strong results from a global trial of Medtronic’s leadless pacemaker, the Micra Transcatheter Pacing System (TPS), have been sent to FDA to support submission for U.S. approval. Here are details of the data, with context from competitor Nanostim's recent trial results.
Dexcom Hitches Its R&D Wagon to Google
Dexcom will spend a big chunk of its R&D budget in 2016 on its partnership with Google to bring smaller and cheaper CGM products to market.